Derfor forventes samtidig administration af febuxostat og andre CYP2D6- substrater ikke at kræve dosisjustering af disse stoffer.
Thus, co-administration of febuxostat with other CYP2D6 substrates is not expected to require any dose adjustment for those compounds.